Literature DB >> 20493818

A combined ex vivo and in vivo RNAi screen for notch regulators in Drosophila reveals an extensive notch interaction network.

Abil Saj1, Zeynep Arziman, Denise Stempfle, Werner van Belle, Ursula Sauder, Thomas Horn, Markus Dürrenberger, Renato Paro, Michael Boutros, Gunter Merdes.   

Abstract

Notch signaling plays a fundamental role in cellular differentiation and has been linked to human diseases, including cancer. We report the use of comprehensive RNAi analyses to dissect Notch regulation and its connections to cellular pathways. A cell-based RNAi screen identified 900 candidate Notch regulators on a genome-wide scale. The subsequent use of a library of transgenic Drosophila expressing RNAi constructs enabled large-scale in vivo validation and confirmed 333 of 501 tested genes as Notch regulators. Mapping the phenotypic attributes of our data on an interaction network identified another 68 relevant genes and revealed several modules of unexpected Notch regulatory activity. In particular, we note an intriguing relationship to pyruvate metabolism, which may be relevant to cancer. Our study reveals a hitherto unappreciated diversity of tissue-specific modulators impinging on Notch and opens new avenues for studying Notch regulation and function in development and disease. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493818     DOI: 10.1016/j.devcel.2010.03.013

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  77 in total

Review 1.  Trithorax group proteins: switching genes on and keeping them active.

Authors:  Bernd Schuettengruber; Anne-Marie Martinez; Nicola Iovino; Giacomo Cavalli
Journal:  Nat Rev Mol Cell Biol       Date:  2011-11-23       Impact factor: 94.444

Review 2.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

3.  In vivo reconstitution of gamma-secretase in Drosophila results in substrate specificity.

Authors:  Denise Stempfle; Ritu Kanwar; Alexander Loewer; Mark E Fortini; Gunter Merdes
Journal:  Mol Cell Biol       Date:  2010-04-26       Impact factor: 4.272

Review 4.  RNAi screening: new approaches, understandings, and organisms.

Authors:  Stephanie E Mohr; Norbert Perrimon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-09-22       Impact factor: 9.957

5.  The ubiquitin-specific protease 12 (USP12) is a negative regulator of notch signaling acting on notch receptor trafficking toward degradation.

Authors:  Julien Moretti; Patricia Chastagner; Chih-Chao Liang; Martin A Cohn; Alain Israël; Christel Brou
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

6.  Regulation of Notch Signaling by an Evolutionary Conserved DEAD Box RNA Helicase, Maheshvara in Drosophila melanogaster.

Authors:  Satya Surabhi; Bipin K Tripathi; Bhawana Maurya; Pradeep K Bhaskar; Ashim Mukherjee; Mousumi Mutsuddi
Journal:  Genetics       Date:  2015-09-22       Impact factor: 4.562

Review 7.  Drosophila RNAi screening in a postgenomic world.

Authors:  Chris Bakal
Journal:  Brief Funct Genomics       Date:  2011-07-12       Impact factor: 4.241

8.  Glycolysis supports embryonic muscle growth by promoting myoblast fusion.

Authors:  Vanessa Tixier; Laetitia Bataillé; Christelle Etard; Teresa Jagla; Meltem Weger; Jean Philippe Daponte; Uwe Strähle; Thomas Dickmeis; Krzysztof Jagla
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

9.  Botch promotes neurogenesis by antagonizing Notch.

Authors:  Zhikai Chi; Jianmin Zhang; Akinori Tokunaga; Maged M Harraz; Sean T Byrne; Andrew Dolinko; Jing Xu; Seth Blackshaw; Nicholas Gaiano; Ted M Dawson; Valina L Dawson
Journal:  Dev Cell       Date:  2012-03-22       Impact factor: 12.270

Review 10.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.